Zoetis Inc Cl A (ZTS)
155.00 x 1 158.16 x 3
Pre-market by (Cboe BZX)
156.48 -1.04 (-0.66%) 02/18/25 [NYSE]
155.00 x 1 158.16 x 3
Pre-market 158.16 +1.68 (+1.07%) 08:03 ET
for Tue, Feb 18th, 2025
Results
download Want to compare other data? Select FieldsSymbol | ZTS | TAK | UTHR | ||
Company | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | ||
Price Information | |||||
Exchange | NYSE | NYSE | NASDAQ | ||
Open | 156.46 | 13.81 | 370.00 | ||
High | 157.08 | 13.97 | 374.35 | ||
Low | 154.32 | 13.76 | 366.00 | ||
Last | 156.48 | 13.90 | 372.83 | ||
Change | -1.04 | +0.36 | +2.25 | ||
% Change | -0.66% | +2.66% | +0.61% | ||
Volume | 6,903,800 | 1,689,900 | 431,900 | ||
20-Day Average Volume | 3,447,735 | 1,896,000 | 365,855 | ||
Previous Close | 157.52 | 13.54 | 370.58 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 169.57 | 13.36 | 362.29 | ||
20-Day Raw Stochastic | 9.36% | 94.02% | 74.43% | ||
20-Day Relative Strength | 35.34% | 59.48% | 56.32% | ||
Weighted Alpha | -21.11 | -2.44 | +54.61 | ||
Today's Opinion | 88% Sell | 8% Buy | 56% Buy | ||
Previous Opinion | 88% Sell | 48% Sell | 56% Buy | ||
Last Month's Opinion | 72% Sell | 88% Sell | 40% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -8.98% since 02/10/25 | +3.50% since 02/10/25 | +7.87% since 02/10/25 | ||
Low | 154.32 on 02/18/25 | 13.19 on 02/12/25 | 346.49 on 02/11/25 | ||
High | 174.84 on 02/11/25 | 13.97 on 02/18/25 | 374.35 on 02/18/25 | ||
1-Month | |||||
%Chg | -5.67% since 01/17/25 | +7.59% since 01/17/25 | +3.87% since 01/17/25 | ||
Low | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 344.36 on 02/03/25 | ||
High | 177.40 on 02/06/25 | 13.97 on 02/18/25 | 382.61 on 01/28/25 | ||
3-Month | |||||
%Chg | -11.30% since 11/18/24 | +2.73% since 11/18/24 | +3.79% since 11/18/24 | ||
Low | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 344.36 on 02/03/25 | ||
High | 181.85 on 12/13/24 | 14.04 on 12/03/24 | 383.00 on 12/18/24 | ||
6-Month | |||||
%Chg | -14.82% since 08/16/24 | -4.14% since 08/16/24 | +16.15% since 08/16/24 | ||
Low | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 327.96 on 08/19/24 | ||
High | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 417.82 on 11/08/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 70,070,488 | 44,228,060 | 16,644,995 | ||
Shares Outstanding, K | 447,792 | 3,181,875 | 44,645 | ||
Annual Sales | 9,256,000,000 | 29,419,960,000 | 2,327,500,000 | ||
Annual Net Income | 2,486,000,000 | 994,060,000 | 984,800,000 | ||
Last Quarter Sales | 2,317,000,000 | 7,511,170,000 | 748,900,000 | ||
Last Quarter Net Income | 581,000,000 | 156,180,000 | 309,100,000 | ||
60-Month Beta | 0.90 | 0.51 | 0.57 | ||
Per-Share Information | |||||
Most Recent Earnings | 1.40 on 02/13/25 | 0.42 on 01/30/25 | 6.39 on 10/30/24 | ||
Latest Earnings Date | 02/13/25 | 02/06/25 | 02/19/25 | ||
Most Recent Dividend | 0.500 on 01/21/25 | 0.267 on 09/30/24 | N/A | ||
Next Ex-Dividends Date | 04/21/25 | 09/30/24 | N/A | ||
Ratios | |||||
Price/Earnings ttm | 26.61 | 9.54 | 16.27 |